Citations 2
Clinical Recommendations for Remote Robotic Assisted Surgery From the CRSA 2025 International Consensus Conference
Raptis, Dimitri Aristotle , Kavoussi, Louis, Wren, Sherry M. , Fowler, Dennis, Anvari, Mehran, Bianco, Francesco, Liang, Xiao, Li, Zheyong, Yin, Xiaoyu, Piccoli, Micaela, Marks, John, Shen, Baiyong, Ko, Clifford, Seeliger, Barbara, Hagendoorn, Jeroen, Essani, Rahila, Walsh, R. Matthew, Oleynikov, Dmitry, Jones, Stephanie B., Bindal, Vivek , Kim, Hyun Koo, Hyung, Woo Jin, Hashimoto, Daniel, Chen, Liaohai Leo, Burt, Bryan M., Lafaro, Kelly, Elli, Fernando, Wilson, Erik, Bianchi, Paolo Pietro, Morgan, Annette, Bartlett, Stephen T., Rashidi, Laila, Yu, Liu, Gawkins, Bill, Hinoul, Piet, Peine, Bill, Woo, Yanghee, Raoof, Mustafa, Jones, Daniel, Deshpande, Supriya, Bernard, Jordana , Wang, Yulun, Broering, Dieter C., Giulianotti, Pier Cristoforo, Fong, Yuman , Raptis, Dimitri , Wren, Sherry M , Aldousari, Saad , Ruurda, Jelle P. H. , Bindal, Vivek , Melstrom, Laleh , Celotto, Francesco , Kudsi, Yusef , Ratti, Francesca , Bernard, Jordana , Kavoussi, Louis R., Fowler, Dennis L. , Anvari, Mehran , Bianco, Francesco Maria , Piccoli, Micaela , Marks, John, Ko, Clifford, Seeliger, Barbara , Hagendoorn, Jeroen , Essani, Rahila, Walsh, R. Matthew , Oleynikov, Dmitry , Hyung, Woo Jin , Hashimoto, Daniel A. , Burt, Bryan M. , Lafaro, Kelly J. , Elli, Fernando, Bianchi, Paolo Pietro, Rashidi, Laila, Hinoul, Piet , Peine, Bill, Woo, Yanghee , Raoof, Mustafa , Jones, Daniel, Deshpande, Supriya , Bröering, Dieter C. , Giulianotti, Pier Cristoforo
World Journal of Surgery | July 14, 2026 | Volume: 50 | Issue: 8 | Pages: 2274-2288
ABSTRACT Background Implementation of remote robotic‐assisted surgery (rRAS) has the potential to significantly improve access to high‐quality surgical care for patients worldwide. Advances in robotic systems and telecommunications now enable highly reliable, low latency, and cybersecure connectivity. These technological developments, together with the broader adoption of telemedicine, have driven an increasing interest in the implementation of rRAS. Methods The Clinical Robotic Surgery Association (CRSA) convened a conference to develop international clinical recommendations for rRAS using the Danish Model of Consensus. The society identified five key issue categories and invited a panel of experts to address specific questions for each. Panel members and a jury of 10 unbiased, non‐expert in rRAS professionals participated in a day‐long conference on November 19, 2025 (Los Angeles, USA). During the conference, participants presented, discussed, and reached consensus on specific guidelines relevant to each category. Immediately after the conference, the jury reviewed and approved the recommended guidelines. Results Multiple recommendations were approved for each of the following categories: Operating Models, Roles and Responsibilities (2 recommendations), Clinical Pathway (2 recommendations), Emergency Management (8 recommendations), Technical Considerations (5 recommendations), and Medico‐legal and Ethical Considerations (4 recommendations). Conclusions There was consensus that with recent advances in telecommunication and robotic technologies, rRAS can be offered safely and effectively if the identified safeguards are realized. Adoption of rRAS is expected to continue advancing rapidly.
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial
Shikora, Scott A. , Wolfe, Bruce M. , Anvari, Mehran , Gibbons, Robert D. , Ikramuddin, Sayeed , Miller, Christopher J. , Knudson, Mark B., Tweden, Katherine S. , Sarr, Michael G. , Apovian, Caroline M , Sarwer, David B , Billington, Charles J.
Journal of Obesity | July 12, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-8
Background/Objectives. Vagal block therapy (vBloc) is effective for moderate to severe obesity at one year.Subjects/Methods. The ReCharge trial is a double-blind, randomized controlled clinical trial of 239 participants with body mass index (BMI) of 40 to 45 kg/m or 35 to 40 kg/m with one or more obesity-related conditions. Interventions were implantation of either vBloc or Sham devices and weight management counseling. Mixed models assessed percent excess weight loss (%EWL) and total weight loss (%TWL) in intent-to-treat analyses. At 18 months, 142 (88%) vBloc and 64 (83%) Sham patients remained enrolled in the study.Results. 18-month weight loss was 23% EWL (8.8% TWL) for vBloc and 10% EWL (3.8% TWL) for Sham (P<0.0001). vBloc patients largely maintained 12-month weight loss of 26% EWL (9.7% TWL). Sham regained over 40% of the 17% EWL (6.4% TWL) by 18 months. Most weight regain preceded unblinding. Common adverse events of vBloc through 18 months were heartburn/dyspepsia and abdominal pain; 98% of events were reported as mild or moderate and 79% had resolved.Conclusions. Weight loss with vBloc was sustained through 18 months, while Sham regained weight between 12 and 18 months. vBloc is effective with a low rate of serious complications.